Advisory committee meetings help FDA scientists make decisions and increase public understanding of drug regulation, and ...

The FDA is moving to scale back its long-standing use of expert panels to review drug applications, KFF Health News reported Sept. 12. George Tidmarsh, MD, PhD, director of the FDA’s Center for Drug ...

The FDA is signaling fresh control over the promotion of copycat drugs under President Donald Trump’s executive order to rein ...

On September 9, 2025, the U.S. Food and Drug Administration (FDA) announced it is launching a targeted initiative to combat deceptive drug advertising.

U.S. regulators will begin offering faster reviews to new medicines that administration officials deem as promoting “the health interests of Americans,” under a new initiative announced Tuesday.

The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for reviewing a New Drug Application (NDA) or Biologics License Application (BLA ...

The directive focuses not only on TV advertising by the pharmaceutical industry but also on ads on social media and digital ...

Ingredients not on the green list for GLP-1 drugs in compliance with FDA standards are subject to detention without examination at the border.

Top Food and Drug Administration regulator Vinay Prasad has regained his role as the agency’s chief medical and scientific ...

The FDA says Cheerios ads improperly market the cereal as a cholesterol drug. May 13, 2009 — -- For decades, a sunny yellow box of Cheerios has dominated breakfast tables across the nation. But ...

The vaccine advisory committee is scheduled to meet next week to review and make recommendations for this fall’s updated ...